Ozempic,Mounjaro and the Slow Death of Junk Food

Are Ozempic, Mounjaro and other GLP-1 weight-loss drugs killing junk food? Wall Street thinks they could save America's biggest airlines $580 million a year in fuel, and that is only the start. In 2013, American Airlines took thirty-five pounds of paper out of every cockpit to save fuel. Now weight-loss drugs like Ozempic, Wegovy and Mounjaro are doing something airlines never could: making passengers lighter. In this Industry Shifts episode, we follow GLP-1 drugs out of the pharmacy and into the food economy: shrinking grocery baskets, snack makers like PepsiCo closing sites, "GLP-1 friendly" labels, protein added to everything, whey protein prices more than doubling, and the fall of Beyond Meat and plant-based meat. And we ask why junk food and ultra-processed food may be following the same long, slow path as the cigarette. This video is business and market analysis only. It is not medical, financial or investment advice. CHAPTERS 0:00 Ozempic, airlines and thirty-five pounds of paper 2:37 How GLP-1 drugs quiet "food noise" 5:26 Ozempic and the shrinking grocery basket 7:29 Ultra-processed food: the science and the law 10:10 How PepsiCo, Nestlé and Kraft Heinz are pivoting 13:15 The whey protein squeeze and Beyond Meat's fall 16:30 Is junk food really dying? 18:30 What tobacco teaches the food industry 19:48 The lighter aircraft #Ozempic #GLP1 #JunkFood #mounjaro #wegovy #protein #wheyprotein #beyondmeat #vegan #WeightLossDrugs #FoodIndustry #UltraProcessedFood